Medac Gesellschaft für klinische Spezialpräparate mbH (Manufacturer responsible for primary packaging labelling, secondary packaging, application of protective film (optional), batch control/testing and batch release)
UkraineAll medications by this manufacturer
-
Irinotecan medac
Form: concentrate for infusion solution
Active substance Dosage irinotecan 17.33 mg/ml ATC: L01CE02